CY1105034T1 - Ελαχιστοι υποκινητες και οι χρησεις τους - Google Patents

Ελαχιστοι υποκινητες και οι χρησεις τους

Info

Publication number
CY1105034T1
CY1105034T1 CY20061100645T CY061100645T CY1105034T1 CY 1105034 T1 CY1105034 T1 CY 1105034T1 CY 20061100645 T CY20061100645 T CY 20061100645T CY 061100645 T CY061100645 T CY 061100645T CY 1105034 T1 CY1105034 T1 CY 1105034T1
Authority
CY
Cyprus
Prior art keywords
minimal
motives
reagents
methods
promoter sequences
Prior art date
Application number
CY20061100645T
Other languages
English (en)
Inventor
James T. Fuller
Original Assignee
Powderject Vaccines, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22302848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1105034(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines, Inc. filed Critical Powderject Vaccines, Inc.
Publication of CY1105034T1 publication Critical patent/CY1105034T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Confectionery (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)

Abstract

Περιγράφονται αλληλουχίες ελάχιστων υποκινητών. Περιγράφονται επίσης αντιδραστήρια που συμπεριλαμβάνουν ένα μόριο νουκλεϊκού οξέος το οποίο περιέχει αυτές τις αλληλουχίες των ελάχιστων υποκινητών. Περιγράφονται ακόμα μέθοδοι για τη κατασκευή αυτών των αντιδραστηρίων και μέθοδοι για τη χρήση αυτών των αντιδραστηρίων.
CY20061100645T 1998-10-19 2006-05-17 Ελαχιστοι υποκινητες και οι χρησεις τους CY1105034T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10487198P 1998-10-19 1998-10-19
PCT/US1999/024694 WO2000023592A2 (en) 1998-10-19 1999-10-19 Minimal promoters and uses thereof

Publications (1)

Publication Number Publication Date
CY1105034T1 true CY1105034T1 (el) 2010-03-03

Family

ID=22302848

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100645T CY1105034T1 (el) 1998-10-19 2006-05-17 Ελαχιστοι υποκινητες και οι χρησεις τους

Country Status (14)

Country Link
US (1) US20070009487A1 (el)
EP (1) EP1123396B1 (el)
JP (1) JP2002527527A (el)
AT (1) ATE319826T1 (el)
AU (1) AU766005B2 (el)
CA (1) CA2347369A1 (el)
CY (1) CY1105034T1 (el)
DE (1) DE69930294T2 (el)
DK (1) DK1123396T3 (el)
ES (1) ES2259846T3 (el)
IL (2) IL142680A0 (el)
NZ (1) NZ511798A (el)
PT (1) PT1123396E (el)
WO (1) WO2000023592A2 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026717A1 (en) 1999-10-11 2001-04-19 Needleless Ventures, Inc. Universal anti-infectious protector for needleless injectors
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
KR101225395B1 (ko) 2003-10-10 2013-01-28 파우더젝트 백신, 인코포레이티드 핵산 구조물
US20240123086A1 (en) * 2021-02-24 2024-04-18 University Of Massachusetts Inducible single aav system and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4629782A (en) * 1984-12-21 1986-12-16 Syntex (U.S.A.) Inc. Crystalline form of N-acetylmuramyl-L-α-aminobutyryl-D-isoglutamine
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US5120657A (en) * 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
GB8717430D0 (en) * 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5179022A (en) * 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DK0500799T3 (da) * 1989-11-16 1998-09-14 Univ Duke Partikel-medieret transformation af animalske vævsceller
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5204253A (en) * 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5558644A (en) * 1991-07-16 1996-09-24 Heartport, Inc. Retrograde delivery catheter and method for inducing cardioplegic arrest
US5658892A (en) * 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US5888981A (en) * 1993-06-14 1999-03-30 Basf Aktiengesellschaft Methods for regulating gene expression
WO1995019799A1 (en) * 1994-01-21 1995-07-27 Agracetus, Inc. Gas driven gene delivery instrument
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
FR2735789B1 (fr) * 1995-06-23 1997-07-25 Centre Nat Rech Scient Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
GB9605690D0 (en) * 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
US5891718A (en) * 1996-03-27 1999-04-06 Vical Incorporated Tetracycline inducible/repressible systems
US6156567A (en) * 1996-07-03 2000-12-05 Merial Truncated transcriptionally active cytomegalovirus promoters
DE69732847T2 (de) * 1996-11-08 2006-04-13 Oklahoma Medical Research Foundation, Oklahoma Endothel-spezifischer expression unter einfluss von epcr kontrollelementen
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression
US6368825B1 (en) * 1998-08-10 2002-04-09 Academia Sinica Baculovirus containing minimal CMV promoter

Also Published As

Publication number Publication date
ATE319826T1 (de) 2006-03-15
WO2000023592A2 (en) 2000-04-27
ES2259846T3 (es) 2006-10-16
CA2347369A1 (en) 2000-04-27
EP1123396B1 (en) 2006-03-08
IL142680A (en) 2010-04-15
WO2000023592A9 (en) 2000-09-28
DK1123396T3 (da) 2006-07-10
US20070009487A1 (en) 2007-01-11
EP1123396A2 (en) 2001-08-16
DE69930294T2 (de) 2006-11-02
WO2000023592B1 (en) 2000-09-08
WO2000023592A3 (en) 2000-07-27
IL142680A0 (en) 2002-03-10
NZ511798A (en) 2004-01-30
JP2002527527A (ja) 2002-08-27
AU1707300A (en) 2000-05-08
DE69930294D1 (de) 2006-05-04
PT1123396E (pt) 2006-07-31
AU766005B2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
DE69926797D1 (de) Sequenzierungsverfahren mit signalverstärkern
CO4810232A1 (es) Citoquinas de mamiferos y sus secuencias codificadoras
ATE551352T1 (de) Peptidakzeptorbindungsverfahren
DK1053355T3 (da) PNA- og DNA-konjugater og metoder til fremstilling heraf
DE69213112T2 (de) Verbesserte Methoden zur Nukleinsäure-Amplifizierung
DE69739465D1 (de) Methoden zur Analyse von Nukleinsäure-Molekülen mittels Techniken zur Grössen-bestimmung
DE69739688D1 (de) Hybridpolyketidesynthase I Gen
DE69432419D1 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
DE69607830T2 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
DK0871767T3 (da) Fremgangsmåde til amplificering af specifikke nucleinsyresekvenser
CY1105034T1 (el) Ελαχιστοι υποκινητες και οι χρησεις τους
CY1108288T1 (el) Αντισωματα για το αντιγονο κυτταρων langerhans θηλαστικων και χρησεις τους
ATE268387T1 (de) Verwendungen von nukleinsäuren die ein retrovirus aus schweinen entnommen sind
DE69902796T2 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
DK0877758T3 (da) Oprenset SR-p70-protein
AR016145A1 (es) Citoquinas de mamifero; reactivos relacionados
DE69811997D1 (de) Verfahren zur Reindarstellung von Nukleinsäurederivaten
DE59605167D1 (de) Schilderhalterung
ECSP982583A (es) Genes aislados de proteinas de membranas de mamiferos reactivos relacionados